Delivery Order SPE2DB20D7059-SPE2DB24FQKH9

Award Date 7/25/24
Potential Completion Date 7/26/24
Potential Value $1.1K
Ultimate Awardee
Not listed
Federal Contract Vehicle
Set-Aside Type
No Set-Aside Used
Extent Competed
Full and Open Competition
Major Defense Program
Not listed
Pricing Type
Firm Fixed Price
Place of Performance
Conshohocken, PA 19428, USA
Solicitation Procedures
Negotiated Proposal / Quote
Number Of Offers Received
Not listed
Legislative Mandate
Not listed
National Interest Action
Not listed
Research Type
Not listed
Primary Consortia Member
Not listed
Similar Awards
This federal contract award was issued by the Defense Logistics Agency (DLA) to the prime contractor Amerisourcebergen Drug Corp. The contract, valued at $1,003.20, is a firm fixed-price delivery order for the pharmaceutical product LORYNA 3 MG-0.02 MG TABLET 28S. The contract has an ultimate completion date of November 7, 2024. Amerisourcebergen Drug Corp is a major pharmaceutical distributor that provides a comprehensive range of medical products to federal agencies, particularly within...
This federal contract award, valued at $1,432.26, was issued by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The contract is for the delivery of LORYNA 3 MG-0.02 MG tablets, a pharmaceutical product, with an ultimate completion date of July 25, 2024. The contract type is a Delivery Order with a Firm Fixed Price pricing structure, and it was awarded on July 24, 2024. There is no set-aside designation for...
This federal contract award was issued by the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp, a subsidiary of Amerisourcebergen Corporation. The award is for the delivery of the pharmaceutical product "LORYNA 3 MG-0.02 MG TABLET 28S" with a ceiling value of $1,450.40. The contract is a firm fixed price delivery order with a period of performance through March 19, 2024. Amerisourcebergen Drug Corp is the prime contractor and there is no set-aside designation for this...
This federal contract award, with ID SPE2DB20D3103|SPE2DB24FL7C6, was issued by the Defense Logistics Agency (DLA) to the prime contractor Amerisourcebergen Drug Corp. The contract, valued at $4,077.49, is a Firm Fixed Price Delivery Order for the supply of pharmaceutical products, including the drug LORYNA 3 MG-0.02 MG TABLET 28S. The contract has an ultimate completion date of November 30, 2023. Amerisourcebergen Drug Corp is a major pharmaceutical distributor and healthcare solutions provider...
This is a federal delivery order contract awarded by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp's Corporate Office division. The contract is for the supply of LORYNA 3 MG-0.02 MG TABLET 28S, a pharmaceutical product, with a ceiling value of $1,388.10 and a period of performance through July 12, 2024. This delivery order is issued under a larger Indefinite Delivery Contract (IDC) valued up to $999,999,999.00 that AmerisourceBergen holds with the DLA Troop Support Medical to...
This federal contract award was made by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corporation's Corporate Office division. The $1,517.87 Firm Fixed Price delivery order contract is for the supply of LORYNA 3 MG-0.02 MG TABLET 28S, a pharmaceutical product. The contract has an ultimate completion date of August 6, 2024. AmerisourceBergen is a major supplier of pharmaceutical products and medical supplies to the U.S. federal government, leveraging its extensive supply chain...
This is a federal contract award issued by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The award, valued at $1,133.10, is for the delivery of the pharmaceutical product LORYNA 3 MG-0.02 MG TABLET 28S. This is a firm fixed-price delivery order contract with a completion date of November 16, 2023. The contract does not have a set-aside designation, indicating open competition. AmerisourceBergen holds a...
The federal contract award is from the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The $1,875.38 firm fixed-price delivery order is for the drug product LORYNA 3 MG-0.02 MG TABLET 28S, with a completion date of November 10, 2022. This order is part of Amerisourcebergen's $999,999,999 Indefinite Delivery Contract (IDC) with the DLA Troop Support Medical, which provides a wide range of pharmaceutical...
This is a federal contract award from the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The $4,951.88 Firm Fixed Price Delivery Order contract is for the supply of the pharmaceutical product LORYNA 3 MG-0.02 MG TABLET 28S. The contract has an ultimate completion date of January 23, 2025. AmerisourceBergen holds a significant $999,999,999 Indefinite Delivery Contract (IDC) with the DLA Troop Support Medical,...
This federal contract award was issued by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor, for the delivery of LORYNA 3 MG-0.02 MG tablets. The $9,938.74 firm fixed-price delivery order falls under a larger $999,999,999 Indefinite Delivery Contract (IDC) between AmerisourceBergen and the DLA Troop Support Medical, which enables efficient government procurement of essential pharmaceutical and medical supplies for military healthcare...
  • SPE2DB20D7059
    Indefinite Delivery Contract
  • SPE2DB20D7059-SPE2DB24FQKH9
    Delivery Order

This federal contract award, issued by the Defense Logistics Agency (DLA), was made to AmerisourceBergen Drug Corp (Corporate Office Division) for the supply of the pharmaceutical product LORYNA 3 MG-0.02 MG TABLET 28S. The contract has a ceiling value of $1,090.40 and is a firm fixed-price delivery order with a completion date of July 26, 2024. This contract is not set aside for any particular business type. AmerisourceBergen Drug Corp is a major supplier of pharmaceutical products and medical supplies to the U.S. federal government, including military treatment facilities, veterans' hospitals, and other federal healthcare providers. The company holds several Indefinite Delivery Contracts (IDCs) with government agencies, such as a $999,999,999 IDC with the DLA Troop Support Medical, which serves as a primary vehicle for providing a comprehensive range of medical commodities to support military healthcare programs worldwide.

Generated 1/3/25, 9:33 AM